ClinVar Miner

Submissions for variant NM_000046.5(ARSB):c.753C>G (p.Tyr251Ter) (rs765711776)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000579253 SCV000680732 pathogenic not provided 2018-01-26 criteria provided, single submitter clinical testing The Y251X nonsense variant in the ARSB gene has been reported previously in association with MPSVI and is a common pathogenic variant identified in individuals from the Al-Hofuf area in Saudi Arabia (Sillence et al., 2012; Al-Sannaa et al., 2018). This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay.
Laboratory of Diagnosis and Therapy of Lysosomal Disorders,University of Padova RCV000677594 SCV000803111 pathogenic Mucopolysaccharidosis type 6 2018-01-01 criteria provided, single submitter curation Nonsense variant (PVS1); In vitro functional studies supportive of a damaging effect on the gene product (low to no ARSB activity in homozygotes; PS3); Absent from GnomAD (PM2); Reputable source identifies as pathogenic (PP5)
Invitae RCV000677594 SCV000937682 pathogenic Mucopolysaccharidosis type 6 2018-08-20 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Tyr251*) in the ARSB gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in an individual affected with mucopolysaccharidosis type VI (PMID: 23430861). ClinVar contains an entry for this variant (Variation ID: 488822). Loss-of-function variants in ARSB are known to be pathogenic (PMID: 17458871, 22133300). For these reasons, this variant has been classified as Pathogenic.
CeGaT Praxis fuer Humangenetik Tuebingen RCV000579253 SCV001371503 pathogenic not provided 2020-05-01 criteria provided, single submitter clinical testing
Biochemical Molecular Genetic Laboratory,King Abdulaziz Medical City RCV000677594 SCV001133218 pathogenic Mucopolysaccharidosis type 6 2019-09-26 no assertion criteria provided clinical testing
Natera, Inc. RCV000677594 SCV001457626 pathogenic Mucopolysaccharidosis type 6 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.